Status: current, Defined. Date: 31-Mar 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4679011000168113 | tixagevimab 150 mg / 1.5 mL injection, 1.5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4679021000168118 | tixagevimab 150 mg/1.5 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tixagevimab 150 mg/1.5 mL injection, vial | Is a | tixagevimab | true | Inferred relationship | Some | ||
| tixagevimab 150 mg/1.5 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| tixagevimab 150 mg/1.5 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| tixagevimab 150 mg/1.5 mL injection, vial | has Australian BoSS | tixagevimab | true | Inferred relationship | Some | 1751626142 | |
| tixagevimab 150 mg/1.5 mL injection, vial | has intended active ingredient | tixagevimab | true | Inferred relationship | Some | 1751626142 | |
| tixagevimab 150 mg/1.5 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1511598863 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Evusheld Tixagevimab 150 mg/1.5 mL injection, 1.5 mL vial | Is a | True | tixagevimab 150 mg/1.5 mL injection, vial | Inferred relationship | Some | |
| tixagevimab 150 mg/1.5 mL injection [1.5 mL vial] (&) cilgavimab 150 mg/1.5 mL injection [1.5 mL vial], 1 pack | has MPUU | True | tixagevimab 150 mg/1.5 mL injection, vial | Inferred relationship | Some | 1853743840 |
Reference Sets
Medicinal product unit of use reference set
FHIR